Literature DB >> 8449073

Variants of alpha 1-antitrypsin in Puerto Rican children with asthma.

C Colp1, J Pappas, D Moran, J Lieberman.   

Abstract

A survey of 393 Puerto Rican and 354 non-Hispanic pediatric patients at Beth Israel Hospital, New York, revealed a significantly larger percentage of asthmatic subjects among Puerto Ricans, confirming findings of a study of Puerto Rican adults in New York. Assays of alpha 1-antitrypsin (AAT) concentration and phenotypes in 61 Puerto Rican asthmatic children revealed a significantly larger number with an S or Z variant in AAT phenotype. The AAT concentration was not a significant variable in this relationship, since four of five subjects with intermediate deficient AAT concentrations and a PiM phenotype were among control nonasthmatic Puerto Rican subjects. A family history of asthma was more common among asthmatic than control subjects and was most common for variant AAT phenotypes in either asthmatic or control subjects. We speculate that the S or Z variant of AAT affects the inflammatory response in such a way as to predispose to asthma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449073     DOI: 10.1378/chest.103.3.812

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

Review 1.  Elevated asthma morbidity in Puerto Rican children: a review of possible risk and prognostic factors.

Authors:  M Lara; H Morgenstern; N Duan; R H Brook
Journal:  West J Med       Date:  1999-02

2.  Passive smoking and lung function in alpha(1)-antitrypsin heterozygote schoolchildren.

Authors:  G M Corbo; F Forastiere; N Agabiti; V Dell'Orco; R Pistelli; G Massi; C A Perucci; S Valente
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

Review 3.  Current and Future Burden of Chronic Nonmalignant Liver Disease.

Authors:  Prowpanga Udompap; Donghee Kim; W Ray Kim
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-17       Impact factor: 11.382

4.  Practice variations in treating urban minority asthmatics in Chicago.

Authors:  M McDermott; J Silva; R Rydman; A L Giachello; E Yarzagaray; D Robinson; N Peragallo; H Barquero; J O Arrom
Journal:  J Med Syst       Date:  1996-10       Impact factor: 4.460

5.  Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis.

Authors:  R Mahadeva; W S Chang; T R Dafforn; D J Oakley; R C Foreman; J Calvin; D G Wight; D A Lomas
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

6.  Alpha-1 antitrypsin deficiency alleles and severe cystic fibrosis lung disease.

Authors:  R Mahadeva; S Stewart; D Bilton; D A Lomas
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

Review 7.  Disease modifying genes in cystic fibrosis: therapeutic option or one-way road?

Authors:  Rainer Büscher; Hartmut Grasemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-10-11       Impact factor: 3.000

8.  Variants of alpha 1-proteinase inhibitor in black and white South African patients with focal glomerulosclerosis and minimal change nephrotic syndrome.

Authors:  A C Halkas; M C Gaillard; P D Thomson; S L Green; H Ludewick; U Kala
Journal:  J Med Genet       Date:  1998-01       Impact factor: 6.318

Review 9.  Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology.

Authors:  D A Lomas; H Parfrey
Journal:  Thorax       Date:  2004-06       Impact factor: 9.139

Review 10.  Alpha-1-antitrypsin deficiency: current concepts.

Authors:  Alan T Mulgrew; Clifford C Taggart; N Gerry McElvaney
Journal:  Lung       Date:  2007-06-12       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.